Search

everythinglearnresearchcommunity

for

Search:↓

Some birth control pills can cause hair loss, and switching to ones with less androgen should help.

Finasteride effectively reduces hair loss by decreasing androgen levels.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

Young women with high male hormone levels or PCOS often feel more psychological distress and have a lower quality of life.

Iron deficiency might contribute to hair loss in women.

Serum steroid profiling, especially 11-deoxycortisol, helps distinguish between adrenocortical carcinoma and adenoma, considering sex and functional status.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Androstenedione is better than testosterone for diagnosing PCOS in Indian women.

PCOS is linked to metabolic issues and infertility, needing more research.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Dihydrotestosterone (DHT) is crucial for conditions like male-pattern baldness and acne, and measuring a byproduct, androstanediol glucuronide, is a better way to assess DHT's effects than DHT blood levels.

Melanoma survival rates vary by state and are better where incomes are higher, more people have health insurance and education, and there are more dermatologists.

Free Testosterone Index, bioavailable testosterone, and androstenedione are the most accurate for diagnosing excess male hormones in PCOS.

Two young siblings experienced hair loss without hormone issues or other skin problems.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

Vitamin D levels do not significantly relate to the causes of PCOS or DOR in infertile patients.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Progress has been made in skin and nerve regeneration, but more research is needed to improve methods and ensure safety.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Menopause affects hair and skin; more research needed for treatment.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Hair loss treatments work better with lifestyle changes.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

The perception of excessive hair growth in women as abnormal is more influenced by cultural norms than by medical reasons.